CN110755546A - Traditional Chinese medicine composition for preventing cancer mutation - Google Patents

Traditional Chinese medicine composition for preventing cancer mutation Download PDF

Info

Publication number
CN110755546A
CN110755546A CN201911210113.3A CN201911210113A CN110755546A CN 110755546 A CN110755546 A CN 110755546A CN 201911210113 A CN201911210113 A CN 201911210113A CN 110755546 A CN110755546 A CN 110755546A
Authority
CN
China
Prior art keywords
parts
preventing cancer
medicine composition
chinese medicine
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911210113.3A
Other languages
Chinese (zh)
Inventor
朱成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201911210113.3A priority Critical patent/CN110755546A/en
Publication of CN110755546A publication Critical patent/CN110755546A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/748—Oldenlandia or Hedyotis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for preventing cancer mutation. The traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw material medicines in parts by weight: 20-40 parts of Chinese yew; 20-40 parts of ginseng; 5-15 parts of nervilia fordii; 5-15 parts of barbed skullcap herb; 40-80 parts of oldenlandia; 5-15 parts of plantain; 10-20 parts of astragalus; 10-20 parts of codonopsis pilosula; 10-20 parts of selfheal; 10-16 parts of edible tulip; 5-15 parts of Chinese pulsatilla root; 2-7 parts of agilawood; 5-15 parts of lucid ganoderma. The traditional Chinese medicine composition for preventing cancer mutation provided by the invention can prevent mutation induced by various chemical carcinogens, can inhibit mutation-causing effects of some mixed carcinogens, inhibit cancer cell microangiogenesis, prevent cancer cell metastasis and induce cancer cell apoptosis. The Chinese medicinal composition is scientifically prepared from pure natural Chinese medicaments, and has the effects of promoting blood circulation by removing blood stasis, tonifying qi and blood, strengthening body resistance to eliminate pathogenic factors, softening hardness to dissipate stagnation, delaying senescence of cells of a human body and the like.

Description

Traditional Chinese medicine composition for preventing cancer mutation
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for preventing cancer mutation.
Background
At present, anticancer drugs on the market generally kill in-vivo cells, kill cancer cells and normal cells, so that the immunity of the organism is reduced, the resistance to the outside is weakened, and the liver and kidney functions are damaged.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the traditional Chinese medicine composition for preventing cancer mutation, solves the technical problems and provides the traditional Chinese medicine composition for preventing cancer mutation, which has the effects of inhibiting the mutation-causing effect of some mixed carcinogens, inhibiting the generation of cancer cell microangiogenesis, preventing cancer cell metastasis and inducing cancer cell apoptosis, is scientifically prepared from pure natural traditional Chinese medicines and has the effects of promoting blood circulation to remove blood stasis, tonifying qi and blood, strengthening body resistance to eliminate pathogenic factors, softening hardness to dissipate stagnation and delaying senescence of human cells.
In order to achieve the purpose, the invention provides the following technical scheme:
a Chinese medicinal composition for preventing cancer mutation comprises the following raw material medicines in parts by weight: 20-40 parts of Chinese yew; 20-40 parts of ginseng; 5-15 parts of nervilia fordii; 5-15 parts of barbed skullcap herb; 40-80 parts of oldenlandia; 5-15 parts of plantain; 10-20 parts of astragalus; 10-20 parts of codonopsis pilosula; 10-20 parts of selfheal; 10-16 parts of edible tulip; 5-15 parts of Chinese pulsatilla root; 2-7 parts of agilawood; 5-15 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 30 parts of Chinese yew; 30 parts of ginseng; 10 parts of nervilia fordii; 10 parts of barbed skullcap herb; 60 parts of oldenlandia; 10 parts of plantain; 15 parts of astragalus; 15 parts of codonopsis pilosula; 15 parts of selfheal; 12 parts of edible tulip; 10 parts of Chinese pulsatilla root; 5 parts of agilawood; 10 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 20 parts of Chinese yew; 20 parts of ginseng; 5 parts of nervilia fordii; 7 parts of barbed skullcap herb; 50 parts of oldenlandia; 7 parts of plantain; 13 parts of astragalus; 12 parts of codonopsis pilosula; 13 parts of selfheal; 14 parts of edible tulip; 6 parts of Chinese pulsatilla root; 2 parts of agilawood; 5-15 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 40 parts of Chinese yew; 40 parts of ginseng; 14 parts of nervilia fordii; 15 parts of barbed skullcap herb; 80 parts of oldenlandia; 15 parts of plantain; 20 parts of astragalus; 20 parts of codonopsis pilosula; 20 parts of selfheal; 15 parts of edible tulip; 13 parts of Chinese pulsatilla root; 6 parts of agilawood; 14 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation comprises the following preparation method:
the method comprises the following steps: grinding Taxus chinensis, Ginseng radix, folium Nerviliae Fordii, herba Scutellariae Barbatae, herba Hedyotidis Diffusae, herba plantaginis, radix astragali, radix Codonopsis, Prunellae Spica, Pseudobulbus Cremastrae Seu pleiones, radix Pulsatillae, lignum Aquilariae Resinatum and Ganoderma into powder of 70-100 mesh;
step two: adding Mel into the Chinese medicinal powder, stirring, and making into pill for administration.
Wherein the traditional Chinese medicine powder in the step two is directly taken by flushing water.
The invention has the beneficial effects that: the pure traditional Chinese medicine composition provided by the invention is a cancer mutation prevention combination, has certain effects of preventing and treating all cancers, can be taken for a long time, is safe, has no toxic or side effect, is simple and convenient to take orally, and does not have any harm to a human body.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A Chinese medicinal composition for preventing cancer mutation comprises the following raw material medicines in parts by weight: 20-40 parts of Chinese yew; 20-40 parts of ginseng; 5-15 parts of nervilia fordii; 5-15 parts of barbed skullcap herb; 40-80 parts of oldenlandia; 5-15 parts of plantain; 10-20 parts of astragalus; 10-20 parts of codonopsis pilosula; 10-20 parts of selfheal; 10-16 parts of edible tulip; 5-15 parts of Chinese pulsatilla root; 2-7 parts of agilawood; 5-15 parts of lucid ganoderma.
Example 1:
a traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 30 parts of taxus chinensis and 30 parts of ginseng; 10 parts of nervilia fordii; 10 parts of barbed skullcap herb; 60 parts of oldenlandia; 10 parts of plantain; 15 parts of astragalus; 15 parts of codonopsis pilosula; 15 parts of selfheal; 12 parts of edible tulip; 10 parts of Chinese pulsatilla root; 5 parts of agilawood; 10 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation comprises the following preparation method:
the method comprises the following steps: grinding Taxus chinensis, Ginseng radix, folium Nerviliae Fordii, herba Scutellariae Barbatae, herba Hedyotidis Diffusae, herba plantaginis, radix astragali, radix Codonopsis, Prunellae Spica, Pseudobulbus Cremastrae Seu pleiones, radix Pulsatillae, lignum Aquilariae Resinatum and Ganoderma into 70 mesh Chinese medicinal powder;
step two: adding Mel into the Chinese medicinal powder, stirring, and making into pill for administration.
Example 2:
a traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 20 parts of Chinese yew; 20 parts of ginseng; 5 parts of nervilia fordii; 7 parts of barbed skullcap herb; 50 parts of oldenlandia; 7 parts of plantain; 13 parts of astragalus; 12 parts of codonopsis pilosula; 13 parts of selfheal; 14 parts of edible tulip; 6 parts of Chinese pulsatilla root; 2 parts of agilawood; 5-15 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation comprises the following preparation method:
the method comprises the following steps: grinding Taxus chinensis, Ginseng radix, folium Nerviliae Fordii, herba Scutellariae Barbatae, herba Hedyotidis Diffusae, herba plantaginis, radix astragali, radix Codonopsis, Prunellae Spica, Pseudobulbus Cremastrae Seu pleiones, radix Pulsatillae, lignum Aquilariae Resinatum and Ganoderma into 100 mesh powder;
step two: adding Mel into the Chinese medicinal powder, stirring, and making into pill for administration.
Example 3:
a traditional Chinese medicine composition for preventing cancer mutation is prepared from the following raw medicines in parts by weight: 40 parts of Chinese yew; 40 parts of ginseng; 14 parts of nervilia fordii; 15 parts of barbed skullcap herb; 80 parts of oldenlandia; 15 parts of plantain; 20 parts of astragalus; 20 parts of codonopsis pilosula; 20 parts of selfheal; 15 parts of edible tulip; 13 parts of Chinese pulsatilla root; 6 parts of agilawood; 14 parts of lucid ganoderma.
A traditional Chinese medicine composition for preventing cancer mutation comprises the following preparation method:
the method comprises the following steps: grinding Taxus chinensis, Ginseng radix, folium Nerviliae Fordii, herba Scutellariae Barbatae, herba Hedyotidis Diffusae, herba plantaginis, radix astragali, radix Codonopsis, Prunellae Spica, Pseudobulbus Cremastrae Seu pleiones, radix Pulsatillae, lignum Aquilariae Resinatum and Ganoderma into 80 mesh Chinese medicinal powder;
step two: the Chinese medicinal powder is added with Mel, stirred, and administered with water.
The research process of the invention is more than ten years, through systematic observation of 100 patients taking the preparation of the invention, the effective rate of clinical symptoms reaches 97 percent, the symptoms and physical signs disappear after generally taking the preparation for 3 to 6 months, 35 cases are rechecked, and no recurrence occurs.
The classic case:
a moulting woman, 39 years old, Guangxi Nanning City. After the patient suffers from the hysteromyoma by examination, the result of reexamination shows that the hysteromyoma disappears and does not relapse after the treatment of the formula for half a year.
Mr. Tang Dynasty, age 45, Guangxi Guilin people, congenital hemangioma of perineum, diffuse development, cause peritonitis and pleuritis, through the treatment of this recipe for more than three years, peritonitis and pleuritis are fully cured, the tumor body shrinks by 70%, and after continuing taking this recipe, the cure is fully cured, no recurrence is seen so far.
The modern plum can eat fluid food for three days and can eat normal food for ten days after the administration of the formula, so that the physical strength and the immunity are gradually enhanced, and the indexes of cancer cells are more than two years after the administration of the formula.
The invention takes ginseng, radix codonopsitis, ganoderma lucidum and ophiorrhiza pumila as monarch drugs, other drugs as ministerial drugs, and the monarch drugs and the ministerial drugs supplement each other, thereby improving the drug effect.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (6)

1. The traditional Chinese medicine composition for preventing cancer mutation is characterized by comprising the following raw material medicines in parts by weight: 20-40 parts of Chinese yew; 20-40 parts of ginseng; 5-15 parts of nervilia fordii; 5-15 parts of barbed skullcap herb; 40-80 parts of oldenlandia; 5-15 parts of plantain; 10-20 parts of astragalus; 10-20 parts of codonopsis pilosula; 10-20 parts of selfheal; 10-16 parts of edible tulip; 5-15 parts of Chinese pulsatilla root; 2-7 parts of agilawood; 5-15 parts of lucid ganoderma.
2. The traditional Chinese medicine composition for preventing cancer mutation according to claim 1, which is prepared from the following raw material medicines in parts by weight: 30 parts of Chinese yew; 30 parts of ginseng; 10 parts of nervilia fordii; 10 parts of barbed skullcap herb; 60 parts of oldenlandia; 10 parts of plantain; 15 parts of astragalus; 15 parts of codonopsis pilosula; 15 parts of selfheal; 12 parts of edible tulip; 10 parts of Chinese pulsatilla root; 5 parts of agilawood; 10 parts of lucid ganoderma.
3. The traditional Chinese medicine composition for preventing cancer mutation according to claim 1, which is prepared from the following raw material medicines in parts by weight: 20 parts of Chinese yew; 20 parts of ginseng; 5 parts of nervilia fordii; 7 parts of barbed skullcap herb; 50 parts of oldenlandia; 7 parts of plantain; 13 parts of astragalus; 12 parts of codonopsis pilosula; 13 parts of selfheal; 14 parts of edible tulip; 6 parts of Chinese pulsatilla root; 2 parts of agilawood; 5-15 parts of lucid ganoderma.
4. The traditional Chinese medicine composition for preventing cancer mutation according to claim 1, which is prepared from the following raw material medicines in parts by weight: 40 parts of Chinese yew; 40 parts of ginseng; 14 parts of nervilia fordii; 15 parts of barbed skullcap herb; 80 parts of oldenlandia; 15 parts of plantain; 20 parts of astragalus; 20 parts of codonopsis pilosula; 20 parts of selfheal; 15 parts of edible tulip; 13 parts of Chinese pulsatilla root; 6 parts of agilawood; 14 parts of lucid ganoderma.
5. The traditional Chinese medicine composition for preventing cancer mutation according to claim 1, which is prepared by the following steps:
the method comprises the following steps: grinding Taxus chinensis, Ginseng radix, folium Nerviliae Fordii, herba Scutellariae Barbatae, herba Hedyotidis Diffusae, herba plantaginis, radix astragali, radix Codonopsis, Prunellae Spica, Pseudobulbus Cremastrae Seu pleiones, radix Pulsatillae, lignum Aquilariae Resinatum and Ganoderma into powder of 70-100 mesh;
step two: adding Mel into the Chinese medicinal powder, stirring, and making into pill for administration.
6. The Chinese medicinal composition for preventing cancer mutation according to claim 1, wherein the Chinese medicinal powder in the second step is administered by direct water flushing.
CN201911210113.3A 2019-11-29 2019-11-29 Traditional Chinese medicine composition for preventing cancer mutation Pending CN110755546A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911210113.3A CN110755546A (en) 2019-11-29 2019-11-29 Traditional Chinese medicine composition for preventing cancer mutation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911210113.3A CN110755546A (en) 2019-11-29 2019-11-29 Traditional Chinese medicine composition for preventing cancer mutation

Publications (1)

Publication Number Publication Date
CN110755546A true CN110755546A (en) 2020-02-07

Family

ID=69340581

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911210113.3A Pending CN110755546A (en) 2019-11-29 2019-11-29 Traditional Chinese medicine composition for preventing cancer mutation

Country Status (1)

Country Link
CN (1) CN110755546A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102366464A (en) * 2011-11-14 2012-03-07 范圣刚 Antitumor traditional Chinese medicinal composition
CN103635199A (en) * 2011-05-09 2014-03-12 佑华·彼得·盛 Herbal composition for treating cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103635199A (en) * 2011-05-09 2014-03-12 佑华·彼得·盛 Herbal composition for treating cancer
CN102366464A (en) * 2011-11-14 2012-03-07 范圣刚 Antitumor traditional Chinese medicinal composition

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
周兰: "中西医结合治疗中晚期恶性肿瘤50例", 《辽宁中医学院学报》 *
杨宝印: "《癌症的中药治疗》", 28 February 1992, 河北科学技术出版社 *
罗忻: "白花蛇舌草治疗恶性肿瘤", 《中医杂志》 *
胡英春等: "扶正祛邪中药治疗恶性肿瘤的临床研究", 《医学理论与实践》 *
赵建成等: "《肿瘤方剂大辞典》", 30 April 2009, 中国古籍出版社 *

Similar Documents

Publication Publication Date Title
Yao et al. Traditional Chinese medicine (TCM) as a source of new anticancer drugs
WO2013071727A1 (en) Anti-tumor traditional chinese medical composition
CN102327544A (en) Traditional Chinese medicinal composition for treating cancer
CN101601800A (en) A kind of Chinese herbal and crude drugs preparations for the treatment of cancer and preparation method thereof
CN101559186B (en) Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis
CN102228595A (en) Chinese prescription energy pure Chinese medicine extract with anti-aging function
CN101850032B (en) Anti-tumor traditional Chinese medicine composition and preparation method and application thereof
CN102861193B (en) Traditional Chinese medicine composition for treating gastric cancer
Cao et al. Traditional Chinese medicine therapy for esophageal cancer: a literature review
CN101357202A (en) Chinese traditional medicine for treating hepatosis and preparation method thereof
CN105213822B (en) A kind of Chinese medicine composition and its application treated phlegm wet and stop up Sheng type essential hypertension
CN103550718B (en) A kind of Chinese medicine composition for the treatment of pulmonary carcinoma
CN102755600A (en) Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence
CN105126030A (en) Zhuang medicine composition assisted in resisting lung cancer
CN110755546A (en) Traditional Chinese medicine composition for preventing cancer mutation
CN104173853A (en) Drug for treating ocular myasthenia gravis
CN104069201A (en) Chaige Qinlian decoction for treating main symptoms of fever and diarrhea
CN104825817A (en) Traditional Chinese medicine preparation with antitumor effect
CN102755560B (en) Traditional Chinese medicine compound reducing chemotherapy side reaction and preparation method and application thereof
CN107468949B (en) Traditional Chinese medicine composition for treating advanced primary liver cancer and preparation method thereof
CN102772763B (en) Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition
CN101829213B (en) Medicine composition for treating asthma and preparation method thereof
CN102327492A (en) Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury
CN101721610B (en) Medicine for treating tumors
Yang et al. Analysis of the rule of medication of compound Chinese traditional patent medicine for digestive system tumors based on data mining.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200207

RJ01 Rejection of invention patent application after publication